 |
|
|
|
|
|
|
|
 |
 |
|
|
|
| Project |
|
Therapeutic Area |
|
Development Stage |
 |
|
|
|
|
|
|
 |
|
|
Telomelysin® (OBP-301) |
|
|
Liver cancer, et al. |
|
 |
| |
OBP-801
(HDAC-I) |
|
Solid tumor,
Hematological malignancies |
| |
Molecular Target |
|
Various solid tumors |
|
|
|
|
|
|
 |
|
|
Festinavir®
(OBP-601) |
|
|
HIV/AIDS |
|
 |
| |
OBP-701 |
|
HCV (shRNAi) |
| |
OBP-AI 1 |
|
HCV (*) |
| |
OBP-AI 2 |
|
HIV/AIDS (*) |
|
|
|
|
|
|
 |
|
|
TelomeScan® (OBP-401) |
|
|
Detecting circulating tumor cells |
|
 |
| |
|
Navigation surgery |
|
|
|
|
|
|
(*) Low molecular compounds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Copyright
(c)2004-2005, Oncolys BioPharma Inc. All rights reserved.
|
|
